• Kristin Constantine Trela, Christopher T Salerno, Emuejevoke Chuba, and Richa Dhawan.
• Department of Anesthesia and Critical Care Medicine, University of Chicago, Chicago, IL, United States. Electronic address: Kristin.trela@bsd.uchicago.edu.
• J. Cardiothorac. Vasc. Anesth. 2024 Sep 1; 38 (9): 204720582047-2058.

AbstractHeart transplantation is the definitive treatment for refractory, end-stage heart failure. The number of patients awaiting transplantation far exceeds available organs. In an effort to expand the donor pool, donation after circulatory death (DCD) heart transplantation has garnered renewed interest. Unlike donation after brain death, DCD donors do not meet the criteria for brain death and are dependent on life-sustaining therapies. Procurement can include a direct strategy or a normothermic regional perfusion, whereby there is restoration of perfusion to the organ before explantation. There are new developments in cold storage and ex vivo perfusion strategies. Since its inception, there has been a steady improvement in post-transplant outcomes, largely attributed to advancements in operative and procurement strategies. In this narrative review, the authors address the unique considerations of DCD heart transplantation, including withdrawal of care, the logistics of procuring and resuscitating organs, outcomes compared with standard donation after brain death, and ethical considerations.Copyright © 2024 Elsevier Inc. All rights reserved.

15 keywords...

hide…